Skip to content
aiqbench takeQuantum Computing

aiqbench analysis

IBM's historic stock decline stems from a supply-chain shock where enterprise clients diverted capital to memory hardware rather than software or mainframes, temporarily dashing revenue expectations. While this event highlights current market volatility in the broader tech sector, it does not fundamentally alter IBM's long-term strategic positioning as a leader in AI infrastructure and quantum computing research. The company remains committed to its high-horizon bets despite short-term earnings misses driven by hardware scarcity rather than a failure of its core technology vision.
Source coveringQuantum Zeitgeist
What this isA model's reading of the article and related coverage, written for aiqbench. Not the publisher's words.

IBM’s 25% Single Day Plunge: The AI Boom’s Biggest Victim May Be The Market’s Anti-AI Trade

Quantum Zeitgeist14 min read

IBM shares fell 25 percent in a single session, the worst day in the company's history, after a memory shortage wrecked its second quarter. We look at what a wounded IBM does next with its most credible long-horizon bet: quantum computing.

Enterprise capex is stampeding into the chips of today. IBM’s answer may be to double down on building the chips of tomorrow. On Tuesday 14 July, IBM shares plunged just over 25 per cent in a single session, closing at around $217. That is the worst day in at least 58 years of trading records, and quite possibly the worst in the 110 years since the company’s predecessor listed on the New York Stock Exchange in 1916. The previous holder of the title was Black Monday in October 1987, when the stock fell 23.7 per cent amid a market-wide collapse. This time there was no market-wide collapse to hide behind. This was IBM’s problem alone, and roughly a quarter of a $272 billion company evaporated before lunch. The trigger was unusual in itself. IBM preannounced its second-quarter results a full week ahead of its scheduled 22 July earnings call, something companies only do when the numbers are bad enough that sitting on them becomes a legal risk. The numbers were bad. Adjusted earnings per share came in at $2.93 against a consensus of $3.02, and revenue landed at $17.2 billion against expectations of $17.86 billion. A $660 million revenue miss…

Excerpt shown under the publisher's RSS terms · 200 words · full text and figures are on the publisher's site

Related coverage